Recombinant multi-species c-MAF/MAF protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine c-MAF/MAF protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a DNA-binding, leucine zipper-containing transcription factor that acts as a homodimer or as a heterodimer. Depending on the binding site and binding partner, the encoded protein can be a transcriptional activator or repressor. This protein plays a role in the regulation of several cellular processes, including embryonic lens fiber cell development, increased T-cell susceptibility to apoptosis, and chondrocyte terminal differentiation. Defects in this gene are a cause of juvenile-onset pulverulent cataract as well as congenital cerulean cataract 4 (CCA4). Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2010]
The Alternative Names of target: 2810401A20Rik,A230108G15Rik,AYGRP,C-Maf,CCA4,CTRCT21,MAF,Maf,Maf2,Proto-oncogene c-Maf,Transcription factor Maf,V-maf musculoaponeurotic fibrosarcoma oncogene homolog,c-MAF,c-maf,cMaf

Target products collectionGo to c-MAF/MAF products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP8779-Ag-1/ GM-Tg-hg-IP8779-Ag-2 Human c-MAF/MAF protein Human
GM-Tg-rg-IP8779-Ag-1/ GM-Tg-rg-IP8779-Ag-2 Rat c-MAF/MAF protein Rat
GM-Tg-mg-IP8779-Ag-1/ GM-Tg-mg-IP8779-Ag-2 Mouse c-MAF/MAF protein Mouse
GM-Tg-cynog-IP8779-Ag-1/ GM-Tg-cynog-IP8779-Ag-2 Cynomolgus/Rhesus macaque c-MAF/MAF protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP8779-Ag-1/ GM-Tg-felg-IP8779-Ag-2 Feline c-MAF/MAF protein Feline
GM-Tg-cang-IP8779-Ag-1/ GM-Tg-cang-IP8779-Ag-2 Canine c-MAF/MAF protein Canine
GM-Tg-bovg-IP8779-Ag-1/ GM-Tg-bovg-IP8779-Ag-2 Bovine c-MAF/MAF protein Bovine
GM-Tg-equg-IP8779-Ag-1/ GM-Tg-equg-IP8779-Ag-2 Equine c-MAF/MAF protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP8779-Ag-1/ GM-Tg-hg-IP8779-Ag-2; GM-Tg-rg-IP8779-Ag-1/ GM-Tg-rg-IP8779-Ag-2;
GM-Tg-mg-IP8779-Ag-1/ GM-Tg-mg-IP8779-Ag-2; GM-Tg-cynog-IP8779-Ag-1/ GM-Tg-cynog-IP8779-Ag-2;
GM-Tg-felg-IP8779-Ag-1/ GM-Tg-felg-IP8779-Ag-2; GM-Tg-cang-IP8779-Ag-1/ GM-Tg-cang-IP8779-Ag-2;
GM-Tg-bovg-IP8779-Ag-1/ GM-Tg-bovg-IP8779-Ag-2; GM-Tg-equg-IP8779-Ag-1/ GM-Tg-equg-IP8779-Ag-2
Products Name c-MAF/MAF protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name c-MAF/MAF
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine c-MAF/MAF protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.